Brief: Qualigen Therapeutics, Inc. Reports Financial Results And Corporate Update For Quarter Ending March 31, 2023
Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS INC QUARTERLY LOSS PER SHARE $0.78
* QUALIGEN THERAPEUTICS, INC. REPORTS FINANCIAL RESULTS AND
CORPORATE UPDATE FOR QUARTER ENDING MARCH 31, 2023
* QUALIGEN THERAPEUTICS INC - AS OF MARCH 31, 2023, COMPANY
HAD
APPROXIMATELY $4.4 MILLION IN CASH
Source text for Eikon: ID:nGNXb46rsd
Further company coverage: QLGN.O
Recent news on FF EAI Robotics Ecosystem
See all newsBrief: Faraday Future Intelligent Electric Says FFR To Operate Robotics Business
Brief: Faraday Future Signs Deal to Transfer Robotics Business to FFR at $200 Mln Valuation
Faraday Future climbs after robotics unit deal, strategic upgrade into robotaxi operator
Brief: Aixcrypto Provides Context On Schedule 14C Filing
NASDAQ RESUMED AT 12:42 PM